Skip to main content
Premium Trial:

Request an Annual Quote

MedReleaf ReleafDx

Canadian medical cannabis firm MedReleaf is launching in that country ReleafDx, a genetic test to help physicians in the prescription of cannabis. Based on a cheek swab, the test analyzes a patient's DNA and health conditions, providing information that a doctor can use to determine what cannabis product will work best for an individual, and the proper dosage. Dynacare, a Laboratory Corporation of America company, will manage the sample analysis and results reporting. The cheek swab can be done in doctors' offices or at a Dynacare Laboratory and Health Services Centre. The samples are then sent to Dynacare for analysis. Results are returned to the doctor with recommendations on the proper dosage of medReleaf's products. The test will be available in Canada starting in January.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.